Literature DB >> 19468783

Efficacy of tacrolimus in Sjögren's syndrome-associated CNS disease with aquaporin-4 autoantibodies.

Taku Fukuda, Hirokazu Shiraishi, Tatsufumi Nakamura, Keiko Tanaka, Hideki Nakamura, Akira Tsujino, Yoshihiro Nishiura, Toshiro Yoshimura, Masakatsu Motomura, Katsumi Eguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19468783     DOI： 10.1007/s00415-009-5175-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine.

Authors:  R N Mandler; W Ahmed; J E Dencoff
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

3.  Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2).

Authors:  Luzheng Xue; Shân L Gyles; Anna Barrow; Roy Pettipher
Journal:  Biochem Pharmacol       Date:  2006-12-01       Impact factor: 5.858

4.  Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.

Authors:  Tatsuro Misu; Kazuo Fujihara; Masashi Nakamura; Kazuhiro Murakami; Minoru Endo; Hidehiko Konno; Yasuto Itoyama
Journal:  Tohoku J Exp Med       Date:  2006-07       Impact factor: 1.848

5.  Non-FK506-binding protein-12 neuroimmunophilin ligands increase neurite elongation and accelerate nerve regeneration.

Authors:  Bruce G Gold; David M Armistead; Min-Sheng Wang
Journal:  J Neurosci Res       Date:  2005-04-01       Impact factor: 4.164

6.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Authors:  Shanu F Roemer; Joseph E Parisi; Vanda A Lennon; Eduardo E Benarroch; Hans Lassmann; Wolfgang Bruck; Raul N Mandler; Brian G Weinshenker; Sean J Pittock; Dean M Wingerchuk; Claudia F Lucchinetti
Journal:  Brain       Date:  2007-02-04       Impact factor: 13.501

7.  Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

Authors:  Sophie Delalande; Jérôme de Seze; Anne-Laure Fauchais; Eric Hachulla; Tanya Stojkovic; Didier Ferriby; Sylvain Dubucquoi; Jean-Pierre Pruvo; Patrick Vermersch; Pierre-Yves Hatron
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

Review 8.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

Review 9.  Neuromyelitis optica: changing concepts.

Authors:  Anu Jacob; Marcelo Matiello; Dean M Wingerchuk; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  J Neuroimmunol       Date:  2007-05-21       Impact factor: 3.478

10.  Neuromyelitis optica and non organ-specific autoimmunity.

Authors:  Sean J Pittock; Vanda A Lennon; Jerome de Seze; Patrick Vermersch; Henry A Homburger; Dean M Wingerchuk; Claudia F Lucchinetti; Hélène Zéphir; Kevin Moder; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2008-01
  10 in total
  1 in total

1.  Neuro-Sjögren: Uncommon or underestimated problem?

Authors:  Marta Jaskólska; Magdalena Chylińska; Anna Masiak; Mariusz Siemiński; Marcin Ziętkiewicz; Zenobia Czuszyńska; Żaneta Smoleńska; Zbigniew Zdrojewski
Journal:  Brain Behav       Date:  2020-06-25       Impact factor: 2.708
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.